Literature DB >> 19762695

Cerebral microbleeds are frequent in infective endocarditis: a case-control study.

Isabelle Klein1, Bernard Iung, Julien Labreuche, Agathe Hess, Michel Wolff, David Messika-Zeitoun, Philippa Lavallée, Jean-Pierre Laissy, Catherine Leport, Xavier Duval.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral microbleeds (CMBs) have been described using MRI in patients with cardiovascular risk factors or prior stroke and could be an indicator of small vessel disease. CMBs have been reported in isolated cases of infective endocarditis (IE), but their frequency and the association of CMBs with IE have not yet been studied.
METHODS: A case-control imaging study in a referral institutional tertiary care center was conducted. Systematic brain MRIs, including T2*-weighted sequences, were performed in 60 patients with IE within 7 days of hospital admission and in 120 age- and gender-matched control subjects without IE. Two neuroradiologists, who were blinded to patient characteristics, independently assessed the presence, location, and size of CMBs using a standardized form.
RESULTS: The interobserver agreement level on the presence of CMBs was high with a kappa coefficient range (95% CI) of 0.70 (0.42 to 0.98) for subcortical regions to 0.91 (0.82 to 0.99) for cortical areas. CMBs were more prevalent in patients with IE (57% [n=34]) than in control subjects (15% [n=18]; matched OR, 10.06; 95% CI, 3.88 to 26.07). Moreover, the OR of IE increased gradually with CMBs number with an OR of 6.12 (95% CI, 2.09 to 17.94) for one to 3 CMBs and of 20.12 (95% CI, 5.20 to 77.80) for >3 CMBs.
CONCLUSIONS: CMBs are highly frequent in patients with IE. The strong association found between IE and CMBs supports the need for further evaluation of CMBs as additional diagnostic criteria of IE.

Entities:  

Mesh:

Year:  2009        PMID: 19762695     DOI: 10.1161/STROKEAHA.109.562546

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Neurologic complications in infective endocarditis: identification, management, and impact on cardiac surgery.

Authors:  Nicholas A Morris; Marcelo Matiello; Jennifer L Lyons; Martin A Samuels
Journal:  Neurohospitalist       Date:  2014-10

Review 2.  Imaging of Cerebral Microbleeds.

Authors:  J Linn
Journal:  Clin Neuroradiol       Date:  2015-09-04       Impact factor: 3.649

3.  The importance of preoperative magnetic resonance imaging in valve surgery for active infective endocarditis.

Authors:  Yasushi Takagi; Yoshiro Higuchi; Hiroshi Kondo; Kiyotoshi Akita; Michiko Ishida; Kan Kaneko; Ryo Hoshino; Masato Sato; Motomi Ando
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-07-14

4.  Optimal timing for cardiac surgery in infective endocarditis: is earlier better?

Authors:  François Delahaye; Anne-Marie Antchouey; Guy de Gevigney
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

5.  Cerebral amyloid angiopathy.

Authors:  Navneet Sharma; Sameer Vyas
Journal:  BMJ Case Rep       Date:  2014-02-13

6.  Is brain angio-MRI useful in infective endocarditis management?

Authors:  J Champey; P Pavese; H Bouvaist; M Maillet; A Kastler; B Boussat; P Francois
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-06       Impact factor: 3.267

7.  Cerebral microbleeds after use of extracorporeal membrane oxygenation in children.

Authors:  David S Liebeskind; Nerses Sanossian; Monica L Sapo; Jeffrey L Saver
Journal:  J Neuroimaging       Date:  2012-05-18       Impact factor: 2.486

Review 8.  Bacterial Endocarditis and Cerebrovascular Disease.

Authors:  Brian Silver; Réza Behrouz; Scott Silliman
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

9.  Neurologic complications of infective endocarditis.

Authors:  Amy A Pruitt
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

10.  Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings.

Authors:  Andreas Charidimou; Anant Krishnan; David J Werring; H Rolf Jäger
Journal:  Neuroradiology       Date:  2013-05-25       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.